GlassScriptPhysician profile
Stephen C Hyman
NPI 1437147964
$1,169.92
in general payments reported to CMS, 2019-2025
17 companies · $149 in 2025
The $149 reported for 2025 was more than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $241 · 2020: $186 · 2021: $255 · 2022: $101 · 2023: $108 · 2024: $130 · 2025: $149.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $387.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $386.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $208.79 | 2020-2022 | |
| Stryker Corporation | $171.16 | 2021-2025 | Alphavent, T2 Alpha |
| Fidia Pharma USA INC. | $136.84 | 2020-2023 | Hymovis |
| Pacira Therapeutics, INC. | $135.05 | 2019-2020 | |
| Bioventus LLC | $122.17 | 2019-2025 | Xcell, Gelsyn-3 |
| Globus Medical, INC. | $100.98 | 2024 | Distal Femur Plate System |
| Scilex Pharmaceuticals INC. | $39.17 | 2019 | |
| Depuy Synthes Sales INC. | $38.20 | 2020-2025 | Intrafix, Speedtrap, Orthovisc |
| Pacira Pharmaceuticals Incorporated | $33.84 | 2019-2025 | Iovera |
| Novartis Pharmaceuticals Corporation | $30.37 | 2021 | |
| Biotissue Holdings INC. | $29.36 | 2021 | |
| Nevro Corp. | $27.83 | 2022 | |
| Djo, LLC | $24.71 | 2019 | |
| Smith+Nephew, INC. | $24.13 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $22.20 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $13.52 | 2019 | |
| Medtronic USA, INC. | $11.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Hyman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.